Peptide Vials (Tirzepatide, 30 mg each): 8 weeks (2.55 mg/wk): ~30 mg total 1 vial 12 weeks (2.57.5 mg/wk): ~60 mg total 2 vials 16 weeks (2.510 mg/wk): ~100 mg total 4 vials Insulin Syringes (U100, 1 mL): 8 weeks: 8 syringes (1/week) 12 weeks: 12 syringes (1/week) 16 weeks: 16 syringes (1/week) Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution
In addition to elevated CRP, IL-6, and TNF-, shift workers show altered immune profiles such as a reduced CD4 + /CD8 + T-cell ratio, increased monocyte counts, and impaired NK cell cytotoxicity
GLP-1 use correlated with lower risk of developing substance use disorders involving cannabis, cocaine and opioids
We have identified 2 meta-analyses assessing the combination therapy in CVOTs (Table 1)
Custom Meal Plans: Receive balanced recommendations that prioritize macro- and micronutrients tailored to your body
GLP-1 Weight Loss Program in Dallas, Built Around Real Care If youve been stuck starting and stopping, youre not alone